Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO’s Chan Outlines ‘Chinese Dream’ For Health Care Reforms

Executive Summary

Relying on general practitioners instead of hospitals and increasing compensation to physicians can solve many health care reform issues in China, says the world's top public health official, who also discusses vaccine scandal in China and Zika infection risks during Rio Olympics.

You may also be interested in...



China Expands Grassroots Clinic Prescribing As Cardiovascular Epidemic Looms

In fresh move to reduce reliance on large hospitals to combat the challenge of chronic diseases, China is to allow community clinics to dispense the same drugs as larger hospitals, just as a new Harvard report projects an epidemic of heart disease and stroke in the country.

Sanofi’s Emerging Markets Steady Despite Venezuela Volatility

Sanofi reported steady growth in emerging markets in the second quarter despite the volatility in Venezuela and helped by continued momentum in China.

Sanofi Dives Deep Into Communities As China Elevates GPs’ Role

After bagging initial success in China's county hospital market, Sanofi is now targeting another potentially huge sector to drive growth: urban health service centers. While a policy tailwind to emphasize GPs’ role will help, segmented health insurance coverage, poor care quality, and lack of education will make the company's ambitious goal challenging.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS118884

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel